Anastasia Chrysovalantou Chatziioannou is a Scientist specializing in metabolomics and analytical chemistry at the Nutrition and Metabolism Branch of the International Agency for Research on Cancer (IARC). Her work focuses on developing advanced analytical techniques for clinical biomarker identification, particularly in neonatal conditions like necrotizing enterocolitis and sepsis. She holds a PhD in Analytical Chemistry from Aristotle University of Thessaloniki (2019), an MSc in Chemical Analysis from National & Kapodistrian University of Athens (2014), and a BSc in Chemistry from Aristotle University (2011). Her research interests emphasize metabolic profiling optimization, proteomics applications in neonatal critical care, and biomarker validation through mass spectrometry. She contributes to international scientific communities via membership in the Metabolomics Society and the Association of Greek Chemists. Key research trends in her publications include applying GC-MS and LC-MS/MS technologies to clinical samples, optimizing sample preparation protocols, and identifying metabolomic signatures for disease diagnosis. Her work bridges analytical chemistry innovations with clinical applications in neonatal and infectious disease contexts.
Dr. Andreas Tzakos is a Professor in the Department of Chemistry at the University of Ioannina, Greece, where he leads a research group focused on medicinal chemistry and drug discovery. His laboratory operates under ISO:17025 accreditation (BAC LAB) and specializes in developing bioimaging agents, drug delivery systems, and theranostic compounds for cancer treatment. His research integrates organic synthesis, biophysical techniques, and computational methods to address challenges in human health and disease. Dr. Tzakos's research spans multiple areas of medicinal chemistry including Near InfraRed Imaging agents (NIRI, NIRII, SWIR) for cancer theranostics Drug delivery vehicles and ProDrugs development Peptide-Drug Conjugates, prodrugs, and small ligands design Natural products formulation to enhance therapeutic potency Pharmacokinetics and bioanalysis using LC-MS platforms His work combines modern robotic synthetic methodologies with biophysical techniques (fluorescence, CD, ITC, DSC) and bioinformatic approaches to characterize molecular interactions and dynamic properties of biological systems. His publications reveal a strong focus on cancer theranostics, with particular emphasis on targeted drug delivery, molecular imaging, and the development of novel compounds with triple antiplatelet activity. The research demonstrates expertise in NMR spectroscopy, computational modeling, and the application of natural products in drug discovery. His scientific achievements have been recognized with numerous awards including: Leonidas Zervas Award (2004) Gardiki-Kouidou Award (2007) EMBO long term fellowship & Medical Research Council fellowship (2004-2008) A prestigious Academy of Athens award in cancer/heart diseases research (2018) Dr. Tzakos serves on the editorial boards of several international journals including Molecules, Biochemistry & Pharmacology: Open Access, and E-Journal of Chemistry. He is also an active reviewer for numerous peer-reviewed journals focused on drug discovery, medicinal chemistry, cancer, and biophysics, and serves as an expert evaluator for national and international research proposals including H2020 projects. His laboratory has developed several patented technologies including electronic tuning methodology for GPCR ligands and systems for natural product analogues production. The Bioanalysis and Pharmacokinetics Laboratory (BAC LAB) he directs operates under ISO/IEC:17025 accreditation, providing high-quality analytical services for drug development research. His team has also developed several computational tools including PRESS (Protein S-Sulfenylation server), DIAB-DB (a database for diabetes drug prediction), and multidimensional fingerprint analysis software for complex mixture assignment.
Irene Panderi is a Professor of Pharmaceutical Analysis at the Faculty of Pharmacy, National and Kapodistrian University of Athens, where she leads research in Pharmaceutical Analysis and Analytical Chemistry. She heads the Laboratory of Pharmaceutical Analysis within the Division of Pharmaceutical Chemistry and has over 20 years of experience in developing analytical methods for drugs, metabolites and bioactive compounds. Education: Degree in Pharmacy, University of Athens (1989) Ph.D. in Pharmaceutical Analysis, Division of Pharmaceutical Chemistry, University of Athens (1994) Post-doctoral research in QSAR and stability studies, University of Athens (1994-2000) Certificate of Auditor / Lead Auditor, International Register of Certificate Auditors, London UK (2004) Irene Panderi's research focuses on developing analytical methods for the analysis of drugs, metabolites and bioactive compounds in pharmaceuticals, cosmeceuticals, biological fluids and human tissues. Her work applies to clinical testing, toxicology studies, doping control and quality control of drugs. She has significant expertise in MALDI-TOF imaging mass spectrometry, hydrophilic interaction liquid chromatography, and mass spectrometry techniques. Her recent research has expanded into cosmetic safety assessment, where she serves as a member of the European Commission's Scientific Committee on Consumer Safety (SCCS), contributing to numerous scientific opinions on cosmetic ingredients and nanomaterials. Panderi's publication record demonstrates a clear evolution from pharmaceutical analysis toward broader applications in cosmetic safety. Her most recent articles (2024-2025) predominantly focus on SCCS opinions regarding cosmetic ingredients, particularly concerning nanomaterials, UV filters, and fragrance components. This reflects her growing role in regulatory science and consumer safety assessment, while maintaining her analytical chemistry expertise. Scientific Distinctions: State Scholarship Foundation, Athens, Greece (1987-1988) State Scholarship Foundation, Athens – Greece (1990-1993) Member of Editorial Boards for Journal of Applied Bioanalysis, Separations, Chromatographic Research International, and Pharmakeftiki Professor Panderi teaches undergraduate courses including Introduction to Laboratory Practices, Pharmaceutical Legislation and Deontology, Analytical Chemistry 2, Pharmaceutical Analysis 2, and Laboratory of Pharmaceutical Analysis. At the graduate level, she instructs Advanced Pharmaceutical Analysis, Clinical Pharmaceutical Analysis, Stability of Pharmaceutical Products, and Bioanalytical techniques. Her international collaborations include visiting professorships at Uppsala University (2007) and Brown University (2012-2013). She maintains an active research laboratory focused on advanced analytical techniques for pharmaceutical and cosmetic applications, with particular emphasis on mass spectrometry and chromatographic methods for complex matrices including biological fluids and human tissues.
Professor Athanasios Vlessidis is a distinguished faculty member in the Department of Chemistry at the University of Ioannina, Greece. He serves as Director of the Section of Inorganic and Analytical Chemistry and has established himself as a leading researcher in analytical chemistry with particular expertise in nanotechnology applications, chemiluminescence, and environmental analysis. Bachelor's Degree (1982-1987): University of Ioannina, School of Sciences, Department of Chemistry PhD (1987-1992): University of Ioannina, School of Sciences, Department of Chemistry, Section of Inorganic and Analytical Chemistry Postdoctoral Research (1989): Department of Chemistry, UMIST University, Manchester, England Postdoctoral Research (1993-1998): Laboratory of Analytical Chemistry, Department of Chemistry, University of Ioannina Professor Vlessidis specializes in molecular and atomic spectroscopy, liquid and gas chromatography, electrochemistry, chemiluminescence applications, flow analysis techniques, and environmental analytical chemistry. His research particularly focuses on the applications of nanotechnology in analytical chemistry and the synthesis and characterization of zeolite catalysts. His work bridges fundamental analytical chemistry with practical environmental and biomedical applications. The recent publications of Professor Vlessidis demonstrate a strong trend toward nanotechnology applications in analytical chemistry, particularly in developing novel sensing platforms using gold nanoparticles, quantum dots, and paper-based devices. His research has evolved from traditional analytical methods toward innovative point-of-care diagnostic tools, environmental monitoring systems, and bioanalytical applications with emphasis on colorimetric and chemiluminescent detection methods. Member of the Hellenic Chemists' Union (EEX) (1987) Member of the Royal Society of Chemistry (GRSC) (1992) Member of the Royal Society of Chemistry (MRSC) (1994) Member of the International Zeolite Association (IZA) (1992) Founding Member of the Hellenic Zeolite Association (HELZA) (1996) Member of the Hellenic Network in Applied Catalysis (HELNAC) (2002) Chartered Scientist (CSci) by the Royal Society of Chemistry (2004-2023) Professor Vlessidis has supervised 44 undergraduate theses, 17 Master's theses, 2 Doctoral dissertations, and 6 practical training students. His research has been supported by numerous grants including European Union projects (STRIDE HELLAS, MEASUREMENTS AND TESTING, ENVIRONMENT), national research programs (PENEDE, YPER), and foundation funding (Alexander S. Onassis Public Benefit Foundation). His work has resulted in 99 peer-reviewed journal publications with over 2,500 citations and an h-index of 28. Professor Vlessidis leads the Laboratory of Analytical Chemistry at the University of Ioannina, where his research team focuses on developing novel analytical methods, particularly in nanotechnology applications for environmental and biomedical analysis. His group has established collaborations with multiple Greek and international universities and participates in major international conferences in analytical chemistry.
Σταλίκας Κωνσταντίνος is a Lecturer in Analytical Chemistry at the Department of Chemistry, University of Ioannina, Greece. He holds a PhD in Analytical Chemistry from the same university (1995) and has held post-doctoral research positions in Spain and Germany. His research focuses on analytical methods for environmental, food, and clinical analysis, with expertise in chromatography, spectrometry, and microextraction techniques. He has led numerous EU-funded projects and serves as a reviewer for high-impact journals like Analytical Chemistry and Environmental Science & Technology . Education: 1988: Chemistry Degree (University of Ioannina) 1995: PhD in Analytical Chemistry (University of Ioannina) Research Interests: Development of analytical methodologies for environmental pollutants, food contaminants, and clinical samples. Techniques include Flow Injection Analysis (FIA), Gas Chromatography (GC), High-Performance Liquid Chromatography (HPLC), and microextraction technologies. His work emphasizes applications in toxicology, phytochemical analysis, and nanomaterial-based sorbents. Publications: Over 70 peer-reviewed articles, primarily in Anal. Chem. , J. Chromatogr. A , and Environ. Sci. Technol. , focusing on analytical method development, environmental monitoring, and toxic compound degradation. Notable contributions include nanoscale sorbent materials for trace analysis and GC-MS protocols for pesticide residues. Awards: NATO Fellowship (1993–1995) Spanish Government Postdoctoral Fellowship (1997) DAAD Fellowship (Germany, 2001) Grants & Projects: Coordinated projects on environmental pollution (e.g., Lake Pamvotis studies) and led initiatives on olive oil wastewater treatment. Active in EU-funded programs like INTERREG and FAIR. Labs & Teams: Formerly affiliated with the European Environmental Research Institute (Ioannina) and collaborated with institutions in Spain (University of Cordoba) and Germany (Technical University of Munich).
Georgios Kokkoris is an Associate Professor at the Department of Analysis, Design and Development of Processes and Systems , National Technical University of Athens (NTUA) , School of Chemical Engineering. His research focuses on plasma processes and microfluidic systems with applications in biomedical engineering, food preservation, and nanotechnology. Leader of the Plasma and Microfluidics Research Group Principal Investigator for projects: plasmAI (Intel-Merck), SALVAGE (HFRI), VortexLC (HORIZON), and LagoMeal (Fisheries Programme) Teaches Transport Phenomena I , Industrial Reactor Engineering , and Microfluidics at NTUA His research combines plasma technology for surface engineering with microfluidic device development , particularly in DNA amplification platforms and biomedical applications. Recent work emphasizes AI integration for plasma etching optimization and sustainable food processing solutions. Notable trends in his 15+ peer-reviewed articles (2019-2023) include: Advancements in cold atmospheric plasma (CAP) for enzyme inactivation in food products Development of PCB-based microreactors for rapid DNA diagnostics Studies on plasma-induced surface roughness across polymers and silicon Innovations in nanoparticle strain sensors for microfluidic flow analysis Applications of plasma nanotexturing for cardiac cell engineering Grants and collaborations span EU Horizon initiatives and national programs, with a focus on technology transfer and interdisciplinary applications.
Konstantinos Georgakopoulos serves as Associate Professor in the Division of Pharmaceutical Chemistry at the Faculty of Pharmacy, National and Kapodistrian University of Athens, where he leads research at the Laboratory of Pharmaceutical Analysis. With over two decades of specialized experience, he is a key figure in global sports antidoping science. His academic credentials include: Degree in Chemical Engineering, National Technical University of Athens (1987) Ph.D. in Chemical Engineering, National Technical University of Athens (1992) Georgakopoulos' research centers on antidoping analytics, specializing in biological fluid analysis for banned substances detection, advanced mass spectrometry applications, laboratory quality systems, and data processing methodologies. His work directly supports international anti-doping agencies through innovative analytical frameworks for detecting performance-enhancing compounds. Analysis of his publication record (2006-2019) reveals consistent advancement in mass spectrometry techniques for antidoping, particularly liquid/gas chromatography coupled with time-of-flight and ion trap systems. Key research trajectories include steroid profiling optimization, designer steroid detection protocols, and quantification methodologies for corticosteroids, ephedrines, and morphine in urine samples. His 2019 work established critical population reference ranges for endogenous steroids to enhance antidoping screening accuracy. He maintains active laboratory operations through the Laboratory of Pharmaceutical Analysis, which gained international recognition for its pivotal role in the Athens 2004 Olympic Games Doping Control Laboratory organization and analytical operations.
Dr. Ioannis (Yannis) Dotsikas is an Associate Professor in the Department of Pharmaceutical Chemistry at the School of Pharmacy, University of Athens. His academic career includes a Degree in Pharmacy (1999), MSc (2001), and PhD (2007) in Pharmaceutical Analysis, followed by postdoctoral research in the same field. His research focuses on advanced analytical techniques such as mass spectrometry, chemometrics, and dried blood spot analysis, with applications in pharmaceutical bioanalysis, neonatal screening, and drug formulation analysis. He teaches undergraduate and graduate courses including Pharmaceutical Analysis I & II, Stability of Pharmaceutical Products, and Advanced Pharmaceutical Analysis. Education: PharmD, University of Athens (1999) MSc in Pharmaceutical Analysis, University of Athens (2001) PhD in Pharmaceutical Analysis, University of Athens (2007) Research Highlights: Pioneering work in robotic automation of solvent extraction for bioanalysis Development of LC-MS/MS methods for genotoxic impurity analysis Optimization of dried blood spot techniques for neonatal screening Key Contributions: Global collaborative projects on newborn screening protocols Innovative applications of chemometrics in experimental design Advancements in mass spectrometry-based quantitative methods His publications (over 300 citations) emphasize methodological innovations in pharmaceutical analysis and clinical diagnostics. He maintains active collaborations across Europe and the Balkans, contributing to both academic and industrial research initiatives.
Yannis L. Loukas is an Associate Professor in the Section of Pharmaceutical Chemistry at the Department of Pharmacy, National and Kapodistrian University of Athens. His expertise spans Pharmaceutical Analysis, Bioanalysis, and Molecular Diagnostics. He holds a PhD in Pharmaceutical Analysis (1992) and completed a postdoctoral fellowship at the London School of Pharmacy (1993–1995). His teaching includes undergraduate courses like Pharmaceutical Analysis I and graduate courses such as Clinical Pharmaceutical Analysis. Research focuses on Quality Control in formulations, Neonatal Screening, and Molecular Analysis with applications in Genomics and Oncology. He actively collaborates with international consortia, including the Region 4 Genetics MS/MS Collaborative consortium for neonatal screening. Recent work emphasizes Next-Generation Sequencing for genetic disorders and advanced LC-MS/MS methodologies for pharmaceutical impurity analysis. Publications highlight innovations in pharmacokinetic analysis, gene mutation studies, and clinical biomarker research. Professional memberships include the Royal Pharmaceutical Society’s Pharmaceutical Analysis Group and the Controlled Release Society. His lab advances analytical techniques for drug development and clinical diagnostics.
Dr. Andreas Tzakos is a Professor in the Department of Chemistry at the University of Ioannina, Greece. He leads the ISO:17025-accredited Bioanalysis and Pharmacokinetics Lab (BAC LAB), focusing on molecular-level cancer diagnostics, theranostics, and tumor-targeted drug delivery systems. His work integrates organic synthesis, bioimaging, and biophysical characterization to develop innovative therapeutic strategies. Research Interests: Cancer diagnostics and theranostics Peptide-drug conjugates and prodrugs NIR/SWIR bioimaging agents Natural product formulation and pharmacokinetics GPCR-targeted ligands Scientific Contributions include 15+ recent articles on topics spanning glioblastoma treatment, antiplatelet agents, and NMR-based drug development. Awards highlight his excellence, including the Leonidas Zervas Award and Academy of Athens Award . He also contributes to software development (PRESS, DIAB-DB) and serves on editorial boards of journals like Molecules and Journal of Drug Delivery .
